Campistol Plana Jaume
Servicio de Neuropediatría, Hospital Universitario Sant Joan de Deu, Barcelona, España. E-mail:
Medicina (B Aires). 2019;79 Suppl 3:2-5.
Phenylketonuria, also known as PKU, is the most frequent congenital inborn error of metabolism. The severe form or classic PKU untreated causes intellectual disability, although with the early detection programs in the neonatal period, diagnosis and treatment prevent the appearance of the symptoms. Despite early diagnosis and treatment we have observed some neurotoxicity in treated PKU patients. We analyzed the factors involved apart from the toxicity due to the high cerebral concentrations of phenylalanine (Phe), the defects of synthesis of neurotransmitters, the alteration of cerebral myelination, the effect of the elevation of Phe in the processes of transport and distribution of neutral amino acids with an abnormal synthesis of brain proteins, plasma and cerebral tyrosine deficiency, the neurotoxicity of Phe metabolites, the defect of cholesterol biosynthesis or the increase of oxidative stress. White matter alterations in early treated PKU patients have an important role in neurological manifestations. The treatment of PKU is for life and is based on the reduction of foods containing Phe combined with the administration of a special formula or tetrahydrobiopterin (BH4) treatment. New therapeutic options will be analyzed.
苯丙酮尿症,也称为PKU,是最常见的先天性代谢缺陷病。未经治疗的严重型或经典型PKU会导致智力残疾,不过通过新生儿期的早期检测项目,诊断和治疗可预防症状的出现。尽管进行了早期诊断和治疗,但我们在接受治疗的PKU患者中仍观察到了一些神经毒性。我们分析了除高脑苯丙氨酸(Phe)浓度导致的毒性之外的相关因素,包括神经递质合成缺陷、脑髓鞘形成改变、Phe升高对中性氨基酸转运和分布过程的影响以及脑蛋白合成异常、血浆和脑酪氨酸缺乏、Phe代谢产物的神经毒性、胆固醇生物合成缺陷或氧化应激增加。早期接受治疗的PKU患者的白质改变在神经学表现中起重要作用。PKU的治疗是终身的,基于减少含Phe食物的摄入,并结合使用特殊配方或四氢生物蝶呤(BH4)治疗。将分析新的治疗选择。